Neuraxis, INC SEC filings NRXS

Neuraxis, INC has 193 filings in SEC EDGAR's recent list, going back to Sep 27, 2022. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (other events). The company's fiscal year ends on December 31.

Neuraxis, INC SEC filings
Form Description Filed Period
8-K Current report
Other events
Oct 14, 2026 Oct 14, 2026
8-K Current report
Officer or director change, Other events
Aug 19, 2026 Jul 24, 2026
8-K Current report
Other events
Jul 10, 2026 Jul 9, 2026
8-K Current report
Shareholder vote results
Jun 12, 2026 Jun 10, 2026
8-K Current report
Other events
Apr 22, 2026 Apr 21, 2026
8-K Current report
Results of operations
Apr 21, 2026 Apr 21, 2026
8-K Current report
Other events
Oct 24, 2025 Oct 23, 2025
8-K Current report
Results of operations
Oct 23, 2025 Oct 23, 2025
8-K Current report
Material agreement
Sep 2, 2025 Aug 29, 2025
8-K Current report
Material agreement, Agreement ended, Officer or director change
Jul 3, 2025 Jul 1, 2025
8-K Current report
Shareholder vote results
Jun 4, 2025 May 29, 2025
8-K Current report
Regulation FD disclosure
May 28, 2025 May 23, 2025
8-K Current report
Material agreement, Other events
May 22, 2025 May 20, 2025
8-K Current report
Material agreement, New debt, Other events
May 21, 2025 May 15, 2025
8-K Current report
Results of operations
Jan 8, 2025 Jan 8, 2025
8-K Current report
Officer or director change
Nov 25, 2024 Nov 19, 2024
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Nov 21, 2024 Nov 15, 2024
8-K Current report
Material agreement, Unregistered share sale
Nov 15, 2024 Nov 9, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
8-K Current report
Material agreement, Unregistered share sale
Oct 18, 2024 Oct 12, 2024
8-K Current report
Unregistered share sale
Sep 13, 2024 Sep 9, 2024
8-K Current report
Shareholder vote results
Aug 21, 2024 Aug 15, 2024
8-K Current report
Results of operations
Aug 9, 2024 Aug 9, 2024
8-K Current report
Officer or director change
Jul 5, 2024 Jun 28, 2024
8-K Current report
Material agreement, New debt
May 28, 2024 May 21, 2024
8-K Current report
Officer or director change
Apr 16, 2024 Apr 10, 2024
8-K Current report
Results of operations, Restatement
Apr 9, 2024 Apr 4, 2024
8-K Current report
Material agreement
Mar 28, 2024 Mar 22, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 11, 2024 Mar 7, 2024
8-K Current report
Material agreement, New debt
Feb 15, 2024 Feb 9, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 31, 2024 Jan 25, 2024
8-K Current report
Other events
Dec 19, 2023 Dec 19, 2023
8-K Current report
Material agreement, Other events
Nov 14, 2023 Nov 9, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Sep 21, 2023 Sep 21, 2023
8-K Current report
Regulation FD disclosure
Aug 17, 2023 Aug 17, 2023
8-K Current report
Material agreement, Regulation FD disclosure
Aug 9, 2023 Aug 9, 2023

Showing 36 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
NRXS (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Carmel, IN
SEC filer status
, Emerging growth company
SEC CIK
1933567

Other Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.